We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Testing For TB in South Africa to Increase

By HospiMedica staff writers
Posted on 13 Mar 2007
Rapid test kits are being shipped to South Africa to increase testing for tuberculosis (TB).

Medical Services International Inc. More...
(Edmonton, Canada) has begun to ship the kit, which is called VScan, to South Africa at the request of its distributor and as a result of thousands of infected people being sent back to their communities because of inadequate testing methods. VScan rapid test kit for TB is a TB test kit that measures only active TB. There are no false-positives with the VScan TB rapid test kits. Previous testing has shown that the VScan TB test kit has a sensitivity of 80% and a specificity of 100%. These results substantially exceed the accuracy of any other existing TB tests.

Current testing--a standard smear sputum test--failed to diagnose the disease. Specialists have indicated that 60% of the TB cases in South Africa are smear-negative (not detected by a sputum test). The VScan TB rapid test kit can be used to diagnose smear-negative TB cases. Smear-negative TB is more common in people harboring human immunodeficiency virus (HIV).

A report released by the Treatment Action Campaign said that South Africa not only had one of the highest HIV/AIDS rates in the world but also one of the highest incidence rates for TB and this was increasing drastically as HIV epidemic worsened. Of the estimated nine million people who develop active TB every year, most still do not receive a laboratory confirmed diagnosis. TB is highly contagious.

The VScan rapid test kit is a single use, easy-to-use, test for the screening of HIV 1 and 2, hepatitis B and C, TB, dengue fever, malaria, west Nile fever, syphilis, and prostate cancer.

Existing TB tests routinely produce false-positives when a person has previously been vaccinated against TB using some of the vaccines available. This results in further testing that is expensive, stressful to the individual, and time-consuming.


Related Links:
Medical Services International

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Infrared Digital Thermometer
R1B1
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.